Navigation Links
Child mental health experts issue psychiatric medication treatment guidelines for preschoolers
Date:12/3/2007

The number of preschool-age children being treated with stimulants, antidepressants and other psychiatric drugs is on the rise, despite limited research and a lack of clinical practice guidelines. In a first step toward standardizing treatment approaches, child mental health professionals from the Bradley Hasbro Childrens Research Center and 11 other institutions have developed recommendations for specific disorders to help clinicians who are considering medications for children ages 3 to 6.

These guidelines from the Preschool Psychopharmacology Working Group which includes clinicians and researchers in early childhood psychiatric disorders, psychopharmacology, general and behavioral pediatrics, neurodevelopmental processes, and clinical psychology are published in the December issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

Without established treatment guidelines, clinicians and families face a delicate balancing process. If child continues to have severe or dangerous symptoms after non-medication treatments, the physicians and families must weigh the potential risks of medications with the risks of not intervening in complex clinical situations, said lead author Mary Margaret Gleason, M.D., of the Bradley Hasbro Childrens Research Center.

Our goal was to begin to close the gap between practice and evidence by clearly defining the current state of psychopharmacological treatment of preschoolers, encouraging judicious practice, and using existing evidence and clinical consensus to provide treatment guidelines for these young children, added Gleason, whos also a clinical assistant professor of psychiatry at The Warren Alpert Medical School of Brown University.

Gleason and colleagues developed treatment algorithms for nine common mental health disorders based on a review of existing literature on the use of psychiatric medications in preschoolers, knowledge about preschoolers development, available data on school-age children and adolescents, and expert clinical experience.

The algorithms guide the clinician through recommended assessment and treatment steps. The first step in each algorithm is a comprehensive diagnostic assessment, taking into consideration the childs emotional and behavioral symptoms, relationship patterns, medical history and developmental history and status.

If a psychiatric diagnosis is confirmed, the authors recommend clinicians start with family-focused psychotherapy such as parent management training or dyadic (parent-child) psychotherapy before considering medication. However, if the child is not responding and medication is deemed necessary, they suggest it be used in conjunction with psychotherapy.

Treatment algorithms were established for attention deficit and hyperactivity disorder, disruptive behavior disorders, major depressive disorder, bipolar disorder, anxiety disorders, posttraumatic stress disorder, obsessive-compulsive disorder, pervasive developmental disorders (such as autism), and primary sleep disorders.

These guidelines emphasize the importance of a family-focused assessment by clinicians with experience working with young children, the use of psychotherapy as the first line treatment for young children with severe psychiatric disorders, and the value of careful monitoring of symptoms and side effects when treating young children, said Gleason. They are not intended to promote the use of medications; rather, we anticipate that application of these guidelines may actually reduce the number of preschoolers who are taking psychiatric drugs.

The algorithms share five common factors:

  • Assessment and diagnosis at every decision point in order to reassess the diagnosis and formulation both of which are critical, given the rapid development of preschoolers
  • Psychotherapeutic interventions
  • Each step is marked by the level of evidence supporting the recommendation, allowing clinicians to consider the body of evidence and apply it to the individual patient
  • Recommendations for a discontinuation trial after successful medication treatment to reassess the childs symptoms and appropriate treatment
  • Consultation with an expert in child psychiatry if the physician arrives at the end of the algorithm with ongoing impairment and distress

The authors stress that the algorithms represent their best attempt to integrate data and clinical experience; however, clinicians may determine that an alternative approach is indicated in a particular clinical situation.

We hope this information will be useful for clinical practice, highlight opportunities to advocate for the well-being of young children, and encourage future clinical research in treating very young children with both medication and therapy something thats urgently needed in this preschool population, said Gleason.


'/>"/>

Contact: Jessica Collins Grimes
jgrimes2@lifespan.org
401-432-1328
Lifespan
Source:Eurekalert

Related medicine news :

1. Children of depressed moms do better when dad is involved, SLU researcher finds
2. High pollution linked to poor lung function growth in children in Mexico City
3. Genetic predisposition increases childhood asthma risk
4. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
5. Obese Children Miss More School Days
6. Treating diabetes during pregnancy can break link to childhood obesity
7. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
8. Chinas 1-child policy could backfire on its elderly
9. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
10. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
11. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... the election of Patrick McDermott as Chairman of the National Board of Directors. Mr. ... as Chairman of the Board,” stated Leslie A. Chambers , APDA President and ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Stuart ... tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. ... with unmatched results. , Developed by Cynosure, the PicoSure has been approved by the ...
(Date:2/5/2016)... Viejo, CA (PRWEB) , ... February 05, 2016 , ... ... X. Move from on one drop zone to the next using Colorize's dynamic moving ... complements any project. This package includes a 3D slideshow environment with 1 to 5 ...
(Date:2/5/2016)... ... 05, 2016 , ... Health and wellness is a topic that should concern ... they are experiencing an illness. Migraines are a severe form of a headache and ... would not wish the pain on their worst enemy, the feeling can last for ...
(Date:2/5/2016)... ... February 05, 2016 , ... On ... Rare Diseases, a continuing medical education (CME) event presented by the Association for ... kind—and a first for ACCORD, whose mission is to provide education, tools, and ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... OAKS, Calif. , Feb. 5, 2016 Amgen ... 5 th Annual Global Healthcare Conference at 9:15 a.m. ... York City . David W. Meline , executive ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...
(Date:2/5/2016)... 5, 2016  As people age, it is natural ... recommended screenings and tests that are linked with certain ... for the majority of aging individuals, hearing health is ... the 37.5 million American adults who report some trouble ... make hearing health a 2016 healthy aging priority.[1] ...
(Date:2/5/2016)... Aethlon Medical, Inc. (Nasdaq: AEMD ), today ... be presenting at Source Capital Group,s 2016 Disruptive Growth & ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  Mr. ... place at 3:15 p.m. ET. http://www.aethlonmedical.com .  The ... the conclusion of the live event. The panel discussion will ...
Breaking Medicine Technology: